Jak/Stat信号通路在经典CCl4大鼠肝纤维化模型中的动态变化及扶正化瘀方对其影响

王卫真; 孟明辉; 孔丽; 张庆山; 赵素贤; 南月敏

doi:10.3969/j.issn.1001-5256.2014.04.014

Jak/Stat信号通路在经典CCl4大鼠肝纤维化模型中的动态变化及扶正化瘀方对其影响

DOI: 10.3969/j.issn.1001-5256.2014.04.014

1. 河北医科大学第三医院中西医结合肝病科
2. 石家庄市第五医院

基金项目:

百洋肝纤维化基金(Pearl Ocean Liver Fibrosis Grant 006)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2096
- HTML全文浏览量: 20
- PDF下载量: 554
- 被引次数: 0
出版历程
- 收稿日期: 2013-10-28
- 出版日期: 2014-04-20

Role of Jak /Stat pathway in CCl4- induced rat liver fibrosis model and molecular action mechanism of Fuzheng Huayu recipe in treatment of liver fibrosis

Traditional and Western Medical Department of Hepatology, Third Hospital of Hebei Medical University

Research funding:

摘要

摘要:
目的探讨Jak/Stat信号通路在经典的CCl4大鼠肝纤维化模型中的动态变化及扶正化瘀方对其影响。方法复制经典的CCl4大鼠肝纤维化模型和肝纤维化扶正化瘀方干预模型,收集纤维化形成、逆转和干预过程中不同时间的血液和肝组织,观察血清指标、肝组织病理、α-SMA表达及肝组织Jak1、Stat3蛋白和mRNA表达变化。多组间比较采用单因素方差分析。结果 CCl4应用后模型组大鼠肝组织炎症及纤维化逐渐加重,α-SMA及Jak1、Stat3表达逐渐升高,8周时达高峰。8周后随着CCl4停用,大鼠肝组织炎症和纤维化逐渐好转,上述指标亦较前明显降低;扶正化瘀方干预组第4、6、8周时大鼠血清指标,肝组织炎症和纤维化程度、Jak1、Stat3表达均较模型组相同时间点明显降低。结论 Jak/Stat信号通路在肝纤维化发生和逆转中发挥重要作用,扶正化瘀方可通过阻断Jak/Stat通路及减少肝星状细胞活化发挥抗肝纤维化作用。
- 肝硬化 /
- 信号通路 /
- 扶正化瘀方 /
- 大鼠 /
- wistar
Abstract:
Objective To investigate the role of Jak /Stat pathway in the CCl4- induced rat liver fibrosis model and the molecular action mechanism of Fuzheng Huayu recipe in the treatment of liver fibrosis.Methods Experimental rats were randomly divided into control group, CCl4- induced liver fibrosis model group (model group) , and Fuzheng Huayu recipe group (FZHY group) .Blood and liver tissue samples were collected at different time points during fibrosis development, reversion, and intervention.Serum levels of alanine aminotransferase (ALT) and hyaluronic acid (HA) were determined by Olympus AU2700 automatic biochemical analyzer and radioimmunoassay, respectively.The degree of liver fibrosis was evaluated by the Ishak score system.The protein expression of alpha- smooth muscle actin (α-SMA) was measured by immunohistochemistry.The mRNA and protein expression of Jak1 and Stat3 was measured by RT- PCR and Western- Blot, respectively.Comparison between groups was made by one- way analysis of variance.Results During treatment with CCl4, the model group had increasing liver tissue inflammation and fibrosis, as well as elevated protein expression of α- SMA and mRNA and protein expression of Jak1 and Stat3, and these indices reached the peak levels at week 8;later, the rats showed improvements in liver tissue inflammation and fibrosis and significant decreases in the above indices after CCl4were discontinued.At weeks 4, 6, and 8, the FZHY group had significantly decreased serum levels of ALT and HA, significantly reduced liver tissue inflammation and fibrosis, and significantly down-regulated mRNA and protein expression of Jak1 and Stat3, as compared with the model group.Conclusion The Jak / Stat pathway plays an important role in the development and reversion of liver fibrosis.Fuzheng Huayu recipe can reduce liver fibrosis by blocking the Jak / Stat pathway and inhibiting activation of hepatic stellate cells.
- liver fibrosis /
- signaling pathupys /
- Fuzhenghuayu formula /
- rats, wistar /

HTML全文

参考文献(18)

[1]MATSUI F, MELDRUM KK.The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease[J].J Surg Res, 2012, 178 (1) :339-345.

[2]HUANG XY, LIAN JF, JIN LH, et al.Involvement of JAK-STAT signaling in CTGF promoted lung fibroblast-myofibroblast transdifferentiation[J].J Med Res, 2012, 41 (8) :88-91. (in Chinese) 曹晓燕, 廉姜芳, 金丽华, 等.JAK-STAT通路参与CTGF诱导人胚肺成纤维细胞转化的研究[J].中医学研究杂志, 2012, 41 (8) :88-89.

[3]JIANG H, GAO JR, CHEN JF, et al.Hepatoprotective effect of panax notoginseng saponins in hepatic fibrosis rats[J].Chin J Clin Pharmacol Ther, 2013, 18 (10) :1116-1120. (in Chinese) 姜辉, 高家荣, 陈金峰, 等.三七总皂者对肝纤维化大鼠肝脏保护作用的实验研究[J].中国临床药理学与治疗学, 2013, 18 (10) :1116-1120.

[4]KISSELEVA T, BRENNER DA.Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis[J].J Gastroenterol Hepatol, 2007, 22 (Suppl 1) :s73-s78.

[5]ELSHARKAWY AM, OAKLEY F, MANN DA.The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J].Apoptosis, 2005, 10 (5) :927-939.

[6]PAN Q, ZHANG ZB, ZHANG X, et al.Gene expression profile analysis of the spontaneous reversal of rat hepatic fibrosis[J].Dig Dis Sci, 2007, 52 (10) :2591-2600.

[7]TROEGER JS, MEDERACKE I, GWAK GY, et al.Deactivation of hepatic stellate cells during liver fibrosis resolution in mice[J].Gastroenterology, 2012, 143 (4) :1073-1083.

[8]PAN P, LIU SN.PI3K/Akt signaling pathway and hepatic fibroisis[J].J Clin Hepatol, 2013, 29 (5) :389-392. (in Chinese) 潘澎, 刘绍能.PI3K/Akt信号通路与肝纤维化[J].临床肝胆病杂志, 2013, 29 (5) :389-392.

[9]PAN J, JU J.Current perspectives on the JAK/STAT signaling pathway and its activating factors in liver fibrosis[J].J Clin Hepatol, 2013, 29 (5) :393-396. (in Chinese) 潘金, 琚坚.JAK/STAT信号转导通路在肝纤维化形成中的作用[J].临床肝胆病杂志, 2013, 29 (5) :393-396.

[10]WANG Y, GAO B.Functions of signal transducers and activators of transcription (STAT) in the liver[J].J Clin Hepatol, 2012, 28 (11) :805-811. (in Chinese) 王艳, 高斌.JAK-STAT信号通路及STAT蛋白在慢性肝病中的研究进展[J].临床肝胆病杂志, 2012, 28 (11) :805-811.

[11] KOVALOVICH K, de ANGELIS RA, LI W, et al.Increased toxin-induced liver injury and fibrosis in interleukin-6 deficient mice[J].Hepatology, 2000, 31 (1) :149-159.

[12]SMART DE, VINCENT KJ, ARTHOR MJ, et al.Jun D regulates transcription of the tissue inhibitor of metalloproteinase-1 and intedeukin-6 genes in actived hepatic stellate cells[J].J Biol Chem, 2001, 276 (26) :24414-24421.

[13]WANG XH, CAO Q, HU CM.JAK/STAT pathway mediates IL-4-induced typeⅠcollagen expression in human hepatic stellate cell line LX-2[J].Basic Med Sci Clin, 2012, 32 (4) :423-427. (in Chinese) 王晓红, 曹琦, 胡成穆.JAK/STAT通路调节IL-4诱导的肝星状细胞系LX-2Ⅰ型胶原基因的表达[J].基础医学与临床, 2012, 32 (4) :423-427.

[14]NIU LW, CAO Q, LI J, et al.JAK/STAT pathway mediates leptin-inducedⅠcollagen mRNA expression in human hepatic stellate cells[J].Chin Pharmacol Bull, 2007, 23 (10) :1280-1285. (in Chinese) 牛丽文, 曹琦, 李俊, 等.JAK/STAT途径调节瘦素诱导的肝星状细胞Ⅰ型胶原基因的表达[J].中国药理学通报, 2007, 23 (10) :1280-1285.

[15]CAO Q, MAK KM, LIEBER CS.Leptin represses matrix metalloproteinase-1 gene expression in LX 2 human hepatic stellate cells[J].J Hepatol, 2007, 46 (1) :124-133.

[16] HANDY JA, FU PP, KUMAR P, et al.Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis[J].Biochem J, 2011, 440 (3) :385-395.

[17]HU YY.Multi-way pharmacological action of compound traditional Chinese medicine for anti-hepatic fibrosis and its material basis[J].Drug Eval, 2008, 5 (5) :195-197. (in Chinese) 胡义扬.中药复方抗肝纤维化的多途径药理作用及其物质基础[J].药品评价, 2008, 5 (5) :195-197.

[18]JIANG JX, MIKAMI K, VENUGOPAL S, et al.Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways[J].J Hepatol, 2009, 51 (1) :139-148.

施引文献

资源附件(0)

访问统计